The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up
Stem cell-based therapies have recently opened up new horizons for treatment of various types of diseases including diabetes mellitus. However, long-term efficacy and safety of these novel modalities still remain a serious question. Hereby, we aim to report the one-year follow-up results in the diab...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2012-08-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/22152.pdf&manuscript_id=22152 |
id |
doaj-d2483f94f6684e80bfd64a3117ccb42b |
---|---|
record_format |
Article |
spelling |
doaj-d2483f94f6684e80bfd64a3117ccb42b2020-11-25T02:00:32ZengTehran University of Medical SciencesActa Medica Iranica0044-60250173-59692012-08-01508541546The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-upMaryam GhodsiRamin HeshmatMahsa AmoliAbbas-Ali KeshtkarBabak ArjmandHamidreza AghayanParviz HosseiniAli Mohammad SharifiBagher LarijaniStem cell-based therapies have recently opened up new horizons for treatment of various types of diseases including diabetes mellitus. However, long-term efficacy and safety of these novel modalities still remain a serious question. Hereby, we aim to report the one-year follow-up results in the diabetic patients who underwent fetal liver-derived hematopoietic stem cell allotransplantation. Fifty six patients with type one (n=30) and type two (n=26) diabetes, aged 10-58 years old (32.8 ± 16.3) were divided into the intervention and placebo group. The patients in the intervention group underwent fetal liver-derived hematopoietic stem cell transplantation while the patients in the placebo group received 5 ml of normal saline both via an intravenous route. The patients were visited at regular intervals to evaluate the efficacy of transplantation in glycemic control as well as possible complications. In the 6th month of the follow-up, there was a significant decrease in HbA1c levels in all groups without any rise in the fasting c-peptide. However, none of the precipitants transiently or continuously became insulin free in the first year after transplantation. It can be concluded that, in this study, fetal liver-derived hematopoietic stem cell transplantation had no significant effects on glycemic control. The heterogeneity of our patients might account for the negative results. Hence, longer follow-up results will be reported in the near future.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/22152.pdf&manuscript_id=22152Diabetes mellitusFetal hematopoietic stem cellsCell therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maryam Ghodsi Ramin Heshmat Mahsa Amoli Abbas-Ali Keshtkar Babak Arjmand Hamidreza Aghayan Parviz Hosseini Ali Mohammad Sharifi Bagher Larijani |
spellingShingle |
Maryam Ghodsi Ramin Heshmat Mahsa Amoli Abbas-Ali Keshtkar Babak Arjmand Hamidreza Aghayan Parviz Hosseini Ali Mohammad Sharifi Bagher Larijani The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up Acta Medica Iranica Diabetes mellitus Fetal hematopoietic stem cells Cell therapy |
author_facet |
Maryam Ghodsi Ramin Heshmat Mahsa Amoli Abbas-Ali Keshtkar Babak Arjmand Hamidreza Aghayan Parviz Hosseini Ali Mohammad Sharifi Bagher Larijani |
author_sort |
Maryam Ghodsi |
title |
The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up |
title_short |
The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up |
title_full |
The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up |
title_fullStr |
The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up |
title_full_unstemmed |
The Effect of Fetal Liver-Derived Cell Suspension Allotransplantation on Patients with Diabetes: First Year of Follow-up |
title_sort |
effect of fetal liver-derived cell suspension allotransplantation on patients with diabetes: first year of follow-up |
publisher |
Tehran University of Medical Sciences |
series |
Acta Medica Iranica |
issn |
0044-6025 0173-5969 |
publishDate |
2012-08-01 |
description |
Stem cell-based therapies have recently opened up new horizons for treatment of various types of diseases including diabetes mellitus. However, long-term efficacy and safety of these novel modalities still remain a serious question. Hereby, we aim to report the one-year follow-up results in the diabetic patients who underwent fetal liver-derived hematopoietic stem cell allotransplantation. Fifty six patients with type one (n=30) and type two (n=26) diabetes, aged 10-58 years old (32.8 ± 16.3) were divided into the intervention and placebo group. The patients in the intervention group underwent fetal liver-derived hematopoietic stem cell transplantation while the patients in the placebo group received 5 ml of normal saline both via an intravenous route. The patients were visited at regular intervals to evaluate the efficacy of transplantation in glycemic control as well as possible complications. In the 6th month of the follow-up, there was a significant decrease in HbA1c levels in all groups without any rise in the fasting c-peptide. However, none of the precipitants transiently or continuously became insulin free in the first year after transplantation. It can be concluded that, in this study, fetal liver-derived hematopoietic stem cell transplantation had no significant effects on glycemic control. The heterogeneity of our patients might account for the negative results. Hence, longer follow-up results will be reported in the near future. |
topic |
Diabetes mellitus Fetal hematopoietic stem cells Cell therapy |
url |
http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/22152.pdf&manuscript_id=22152 |
work_keys_str_mv |
AT maryamghodsi theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT raminheshmat theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT mahsaamoli theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT abbasalikeshtkar theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT babakarjmand theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT hamidrezaaghayan theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT parvizhosseini theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT alimohammadsharifi theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT bagherlarijani theeffectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT maryamghodsi effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT raminheshmat effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT mahsaamoli effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT abbasalikeshtkar effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT babakarjmand effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT hamidrezaaghayan effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT parvizhosseini effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT alimohammadsharifi effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup AT bagherlarijani effectoffetalliverderivedcellsuspensionallotransplantationonpatientswithdiabetesfirstyearoffollowup |
_version_ |
1724959934225842176 |